Epstein Becker Green

Contributed: Unlocking value in health data: Truveta’s data monetization strategy carries big risks and responsibilities
By Alaap B. Shah and Nivedita B. Patel | 11:54 am | March 05, 2021
Attorneys from Epstein Becker Green talk the liabilities and ethics of the new plan. 
Telebehavioral health regulation was dominated by emergency waivers and fraud enforcement in 2020
By Dave Muoio | 04:14 pm | October 28, 2020
An annual review of state and federal laws regarding behavioral or mental health telemedicine highlights increased interest in the modality from policymakers and regulators.
Applying data science principles to FDA’s PreCert Program: Some scary stuff
By Bradley Merrill Thompson | 03:08 pm | November 01, 2019
Epstein Becker & Green's Bradley Merrill Thompson explains why the FDA PreCert Program's built-in subjectivity and bias toward established entities should worry the healthcare and medical technology industry.
Annual nationwide survey reports increasing telehealth access legislation, bipartisan support
By Dave Muoio | 03:14 pm | October 23, 2019
The Epstein Becker Green report pinpointed the opioid epidemic as a major driving force behind new laws and programs, but coverage restrictions and non-robust parity laws are still hampering adoption within Medicare.
Five regulatory myths keeping bio/pharma out of digital health
By Bradley Merrill Thompson and Chris Bergstrom | 10:22 am | October 27, 2017
Report: Nearly every state has updated its telehealth legislation since last year
By Dave Muoio | 04:36 pm | October 18, 2017
CDS Coalition drops voluntary guidelines for unregulated clinical decision support software
By Jonah Comstock | 02:13 pm | September 01, 2017
Experts band together to offer pro-bono consulting to digital health startups helping the poor
By Jonah Comstock | 10:24 am | December 01, 2014
Bradley Merrill Thompson testifying before Congress last year.